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THIN MEMBRANE SENSOR WITH 
BIOCHEMICAL SWITCH 
This invention was made with Government support 
under contract Nos. NAS8-38470 and NAS8-38965 
awarded by NASA, and Contract No. F33615-90-C- 
0605 awarded by the U.S. Department of the Air Force. 
The Government has certain rights in this invention. 
This is a continuation-in-part of U.S. patent applica- 
tion Ser. No. 481,213, Ned Feb. 20, 1990, now aban- 
doned. 
FIELD OF THE INVENTION 
This invention relates to the detection and monitor- 
ing of the presence of biological agents and immuno- 
genic chemical substances, for foodborne, waterborne, 
and airborne contamination verification, and the expo- 
sure or risk of exposure of uersons to such agents or 
materials in their work enviionment, and is concerned 20 
more particularly with a simple method of achieving 
such detection which can be embodied into a small 
portable element, for example, as a badge or test chip, 
which can be self-contained and direct acting, thereby 
providing a prompt indication of exposure. 
A biosensor method to detect quickly the minute 
presence of chemical or biological agents offers signifi- 
cant promise for early warning hazard evaluation or 
rapid process or system control. Transduction of the 
sensing reactions into an electronic readout in this sys- 30 
tem by means of a biochemical switch is facilitated by 
the present invention. The present invention offers po- 
tential as a portable, miniaturized “first alert” biosensor 
alarm for chemical or biological materials. Its usefulness 
is anticipated for laboratory, industrial, or field applica- 35 
tions such as detection of environmental pollutants, 
chemical or biological substances, botulinum toxin de- 
tection in food packaging, spoilage indication, pathogen 
detection in water treatment, biological screening for 
hepatitis or HIV products or the like, rapid detection of 40 
25 
mkroorganisms br toxins, and detec6on of fugitive 
pharmaceutical materials. 
BACKGROUND OF THE INVENTION 
Prior art methods for high-sensitivity detection of 
chemical and biological materials have typically relied 
on colorimetric or electrometric analyses of enzymatic 
or immunological reactions of the test analytes. Enzyme 
immunoassay (EIA) techniques have been incorporated 
into a large number of biosensor devices employing 
colorimetric or fluorimetric analyses, as exemplified in 
the following U.S. and foreign patents: U.S. Pat. No. 
4,343,782; EP 125,554; EP 128,318; EP 231,010; EP 
288,256; EP 290,269; SU 1,189,224; JP 57,208,457. In a 
typical embodiment, an enzyme-conjugated antigen 
admixed with immobilized antibody reacts competi- 
tively with free test antigen to release the enzyme into 
solution containing its substrate, and subsequent en- 
zyme reaction products are detected by changes in 
color or fluorescence. A drawback of this method is 
background color which limits sensitivity. 
US. Pat. No. 4,343,782 to Shapiro, issued Aug. 10, 
1982, describes a cytological assay procedure for non- 
excitable cells in which their membrane potential mea- 
sured by an optical property of a permeant dye is used 
to determine characteristics of individual cells. Japanese 
Patent No. 57,208,457 to Olympus Optical Co., Ltd., 
published Dec. 21, 1982, describes an automated appa- 
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2 
ratus for staining of cells or tissues, including an indica- 
tor installed for the determination of dye concentration. 
European Patent No. 125,554 to Charlton, published 
Nov. 21, 1984, describes an ion test means having a 
hydrophilic carrier matrix, which consists of a hydro- 
philic carrier matrix loaded with hydrophobic globules 
containing an ionophore, and a reporter substance and 
titanium dioxide, in a test strip attached to a support. 
European’Patent No. 128,318 to Charlton et al., pub- 
lished Dec. 19, 1984, describes the use of substituted 
indonaphthols as reporter substances in detecting ions 
in ionophoretontaining test strips, for the detection of 
ions in aqueous solutions. U.S.S.R. Patent No. 1,189,224 
to Lemeshko and Brovkovich, published Jul. 26, 1983, 
describes a method of determining phospholipids in 
biological membranes, by treating the preparations with 
chloroform-methanol and a molybdenum color reagent. 
European Patent No. 231,010, to Halsey et al., pub- 
lished Aug. 5, 1987, describes a method of solid phase 
enzyme immunoassay and nucleic acid hybridization 
assay, in which a chromogenic material upon changing 
color in the presence of a solid phase enzyme, binds to 
the solid phase. Color change is analyzed on a dip stick, 
for use in allergy testing. European Patent No. 288,256, 
to Toner, published Oct. 26, 1988, describes europium 
chelates with polypyridine and phenanthroline deriva- 
tives for fluorescent labels for immunoassays. 
Electrochemical coupling of EIA permits direct elec- 
tronic readout, but may suffer from similar sensitivity 
limitations. Examples of prior art methods are disclosed 
in the following U.S. and foreign patents: U.S. Pat. No. 
4,214,968; JP 58,103,659; JP 60,44,865; JP 62,64,941; JP 
63,171,355; JP 63,263,468; EP 302,661. U.S. Pat. No. 
4,214,968 to Battaglia et al., issued July 29, 1980, de- 
scribes a dry operative ion selective electrode compris- 
ing a dried salt solution in a hydrophilic polymeric 
binder in the internal reference, in contact with a hydro- 
phobic ion-selective membrane containing an ion car- 
rier dissolved therein. 
Japanese Patent No. 60,44,865 to Fuji Photo Film 
Co., Ltd., published Mar. 11,  1985, describes a multilay- 
ered analytical element for ammonia determination in 
body fluids comprising a water-resistant support coated 
with an ammonia indicator layer, a barrier layer which 
is permeable to ammonia but not to liquid substances, a 
reagent layer which transforms ammonia-forming sub- 
stances to ammonia, and a porous spreading layer. Japa- 
nese Patent No. 58,103,659 to Toshiba Corp., published 
Jun. 20, 1983, describes membranes for ion-selective 
electrodes, including a tetrahydrofuran solution of 
valinomycin dispersed in polyvinyl chloride in the pres- 
ence of dioctyl phthalate and potassium tetraphenylbo- 
ron, dried into a membrane useful for the determination 
of ions in blood. Japanese Patent No. 63,171,355 to 
Tsukada et al., published Jul. 15, 1988, describes a semi- 
conductor chemical sensor for blood analysis, in which 
the surface of a field effect transistor gate on a base is 
coated with a hydrophilic polymer membrane and the 
membrane is treated with electrically accelerated parti- 
cles to form hydrophilic groups. 
Japanese Patent No. 62,64,941 to Takei et al., pub- 
lished Mar. 24, 1987, describes enzyme-immobilized 
membranes for a sensor, in which high molecular 
weight substances are dissolved, the mixture spread and 
air dried, and soaked in a solvent in which the high 
molecular weight component is insoluble, for enzyme 
immobilization. Japanese Patent No. 63,263,460 to Mit- 
sumata et al., published Oct. 31, 1988, describes an im- 
5,328,847 
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munoassay method using an enzyme immunosensor 
electrode, in which an electrode containing immobi- 
lized antibody is inserted into an electrolyte solution, 
enzyme-labelled antigen and a test antigen are added for 
competitive reaction with antibody, and instantaneous 5 
current or potentia1 changes measured for detection of 
the antigen. European Patent No. 302,661 to Vadgama 
et al., published Feb. 8, 1989, describes a supported 
liquid membrane enzyme electrode sensor for analyte 
determination. 10 
Biosensors incorporating electrochemical detection 
with adsorbed, deposited, or embedded receptor agents 
on an electrode are exemplified in the following U.S. 
and foreign patents: U.S. Pat. No. 4,634,599; U.S. Pat. 
NO. 4,661,442; JP 63,153,462; JP 63,206,652; JP 15 
01,59,058; EP 304,447; WO 87,03,095; WO 88,08,972; 
WO 88,09,499; and WO 88,09,808. In these systems, 
analyte detection is typically followed by a change in 
electrical potential or current at an electrode surface. 
Sensitivity and selectivity for specific anal ytes depend 20 
on the nature of the materials used on the electrode, and 
have limited the applicability of these devices. 
Japanese Patent No. 63,153,462 to Takei et al., pub- 
lished Jun. 25, 1988, describes a sensitive field effect 
transistor biosensor containing an aluminum gate- 25 
immobilized biological substance. European Patent No. 
304,947 to Kagayama, published Mar. 1, 1989, describes 
a biosensor containing immobilized physiologically 
active substance and transducer, comDrisinp. a Dair of 
opposing flat plates between which a; antcod;, with 
antigen or enzymes immobilized onto one surface and a 
transducing chemical substance on the other surface. 
PCT International Application No. WO 88,08,972 to 
Cheung et al., published Nov. 17, 1988, describes a 
biosensor comprising a reversibly selective binding 
protein immobilized upon the insulated gate region of a 
field effect transistor on the sensor. PCT International 
Application No. WO 88,09,808 to Taylor and Ma- 
renchic, published Dec. 15, 1988, describes receptor- 
based biosensors and a method of immobilizing and 
stabilizing an active biological receptor in a polymeric 
film onto an electrode. PCT International Application 
No. WO 88,09,499 to Newman, published Dec. 1, 1988, 
describes an optimized capacitive sensor for chemical 
analysis, which relies on biospecific binding between a 
biochemical binding system and the analyte of interest 
to change the dielectric properties of a capacitive affin- 
ity sensor. 
Japanese Patent No. 01,59,058 to Kuriyama, pub- 
lished Mar. 6, 1989, describes an enzyme immunosensor 
and its use in enzyme immunoassay, consisting of a 
semiconductor ion sensor, a spacer, and plate contain- 
ing immobilized antigen or antibody. French Patent 
2,614,422 to Liston et al., published Oct. 28, 1988, de- 
scribes an enzyme electrode and module for determina- 
tion of analytes in physiological fluids, comprising a 
membrane chamber and composite layered membrane, 
an electrode element in contact with the membrane, a 
flow sampler connected with the membrane chamber, a 
wash cell and a sample container, and means for inter- 
mittent transfer of sample and sample and other solu- 
tions. German Patent No. 3,226,045 to Seshimoto et al., 
published Jan. 20, 1983, describes film-like ion selective 
electrodes comprised of a conductive layer adjacent to 
an ion-selective layer, and their use for body fluid analy- 
sis. 
PCT International Application No. WO 87,03,095 to 
Newman, published May 21, 1987, describes a capaci- 
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tive affinity sensor and method for chemical analysis 
and measurement, comprising an open capacitor which 
produces a higher electric field in one volumetric re- 
gion and a lower field in a second region, a biospecific 
binding agent for the analyte localized on the surface 
between the conductors in the first region, and a means 
associated with the capacitor which responds to the 
average dielectric constant in the first chamber. U.S. 
Pat. No. 4,634,599, to Uzgiris, issued Jan. 6, 1987, de- 
scribes a method for making ordered monolayers of 
macromolecules on supported lipid polylayers, for two- 
dimensional crystallization of macromolecules for im- 
aging in electron microscopy. U.S. Pat. No. 4,661,442, 
to Lukens, issued Apr. 28, 1987, describes a process for 
preparing lipid-protein membranes for chemical detec- 
tion, comprising an aqueous medium containing emulsi- 
fied lipid and protein, applying the medium to an ori- 
fice, and evaporating the water to provide a stable 
membrane. 
Membrane electrode biosensors incorporating oxida- 
tive probes, such as those used to detect glucose in 
blood, are exemplified in the following patents: FR 
2,614,422; EP 248,680; JP 62,85,853; JP 01,59,055; JP 
01,60,382. In these systems, a Clark-type oxygen sensing 
electrode is typically coupled to an oxidative enzyme 
such as glucose oxidase, in order to permit analysis of 
the desired biological parameter. Among other factors, 
synthetic membranes used in said systems vary in com- 
position among the biosensor devices. 
Japanese Patent No. 01,60,382 to Asakura, published 
Mar. 7, 1989, describes the manufacture of a fibroin- 
enzyme membrane and its use in an enzyme sensor. 
Japanese Patent No. 01,59,055 to Suetsugu et al., Mar. 6, 
1989, describes water-absorbing layers in biosensors, for 
electrochemical detection of substances based on a reac- 
tion with a redox enzyme and an electron acceptor. 
Japanese Patent No. 62,85,853 to Miyai and Asano, 
published Apr. 20, 1987, describes a membrane for an 
enzyme electrode, comprised of an enzyme such as 
glucose oxidase immobilized on a fine powder carrier 
and supported with a membrane having a fractionating 
molecular weight capable of passing the protein mole- 
cule of the immobilized enzyme. 
European Patent No. 248,680 to Reinhart et al., pub- 
lished Dec. 9, 1987, describes a noninvasive electro- 
chemical apparatus and method for determining blood 
glucose, comprising a membrane means for containing 
glucose oxidase, means for providing oxygen to the 
membrane, and means for measuring the hydrogen per- 
oxide product in the membrane. 
Sensors using gated membrane electrodes, in which a 
reactive material for the analyte of interest is included 
in a membrane whose permeability changes upon reac- 
tion with the analyte, are exemplified in the following 
U.S. and foreign patents: U.S. Pat. No. 4,637,861; U.S. 
Pat. No. 4,776,944; and EP 261,887. Their sensitivity 
and selectivity are determined by the gated membrane 
composition, and can limit the types of agents which 
one can analyze by these methods. Activity of the gate 
material in prior art membranes can be strongly influ- 
enced by subtle physical changes in the membrane. For 
example, Krull, U. J., M. Thompson, E. T. Vandenberg, 
and H. E. Wong (1985) “Langmuir Blodgett Film Char- 
acteristics and Phospholipid Membrane Ion Conduc- 
tion, ” Analytica Chimica Acta 174: 83-94; 95-102, de- 
scribe packing density effects and capacitance measure- 
ments on electrodes with phospholipid membranes. 
Other influences include regulatory substances. For 
5 
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example Montal, M. P. Labarca, D. R. Fredkin, B. A. 
Suarez-Isla, and J. Lindstrom (1984) “Acetylcholine 
Receptor from Torpedo californica Reconstituted in 
Planar Lipid Bilayer Membranes,” Biophysical J. 45: 
165-174, describe effects of bungarotoxin and other ion 5 
channel modulating toxins in phospholipid membranes. 
See also Krueger, B. K., J. F. Worley, and R. J. French 
(1986) “Block of Sodium Channels in Planar Lipid 
Membranes by Guanidinium Toxins and Calcium: Are 
the Mechanisms of Voltage Dependence the Same?” 10 
Annals of the New York Academy of Sciences 479: 
Caras and Janata, “Enzymatically Sensitive Field 
Effect Transistors,” Methods in Enqvrnology, Volume 
137: pages 247-255, 1988, describes the design, fabrica- 15 
tion, principles of operation, applications and theoreti- 
cal limitations of enzymatically coupled field effect 
transistors as solid state biosensors. 
SUMMARY OF THE INVENTION 
The ultimate objective of the present invention is to 
provide a modular electrochemical biosensor for chemi- 
cal and biological target agents, which incorporates a 
reaction between the target agent of interest and a rec- 
ognition biomolecule in a biochemical switch module 25 
coupled with a gated membrane electrode in an indica- 
tor module. The membrane may contain any suitable 
combination of lipids, long-chain (Clz-C24)organic 
compounds, plastic materials or like polymers for physi- 
cal reinforcement. An additional object is to provide a 30 
257-268). 
20 
compact, economical, easily portable, self-contained 
sensor which can be adapted in manufacture for a vari- 
ety of chemical or biological agents. 
Thus, according to the invention, an electrochemical 
biosensor for chemical or biological target agent detec- 
tion is comprised of a bioresponse simulator, which is a 
biochemical switch module containing in film form a 
recognition biomolecule to which is conjugated an ion 
channel blocker moiety which controls ion permeation 
in a gate membrane; a gate membrane containing ion 
channels as a gate material which is sensitive to the 
channel blocker; and a measuring device comprising an 
electrode, which measures ion current changes across 
the gate membrane. In preferred embodiments of the 
’ invention, the recognition biomolecule comprises a 
protein including or conjugated to a recognition moi- 
ety, or a peptide or cell fragment. The recognition moi- 
ety may be a hapten, a nucleic acid fragment, or a recep- 
tor for the target agent of interest. In especially pre- 
ferred embodiments, the recognition biomolecule is an 
albumin or an immunoglobulin type antibody. The 
channel blocker which blocks ion permeation is prefera- 
bly a polyvalent cation, such as dysprosium, gadolinium 
or another trivalent lanthanide, or ruthenium red conju- 
gated to the recognition moiety. The ion channel 
blocker can also be a guanidinium derivative covalently 
linked to the recognition moiety, or a conjugated com- 
plex metal ion such as ruthenium red. 
The gate membrane contains a thin membrane, pref- 
erably of molecular monolayer or bilayer dimensions, in 
either fluid form or solid form, and in a preferred em- 
bodiment, the gate material is a gramicidin antibiotic 
producing gramicidin channels embedded therein. The 
membrane consists of hydrophobic plastic materials 
alone, or in combination with lipids, which impart both 
the structure necessary for gate material function and 
the physical strength necessary to operate in a biosen- 
sor. In preferred embodiments, the membrane contains 
35 
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a mixture of an acrylic polymer such as polylaurylme- 
thacrylate with phosphatidylethanolamine and phos- 
phatidylserine or similar phospholipids or fatty acid 
derivatives, or a mixture of a carboxylated polyacryl- 
amide with minor amounts of surfactant and antibiotic 
activity such as that marketed by Rohm & Haas as a 
pressure-sensitive adhesive under the trade name 
“RHOPLEX N580” with or without similar lipids. The 
membrane may also include styrenepolyvinylpyridine 
copolymers. 
The gated membrane and measuring device may be 
produced separately as an indicator module, to which 
the biochemical switch is applied prior to use. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a schematic view of the biosensor in the 
poised state. 
FIG. 2 shows an equivalent circuit diagram for the 
detection of ion currents across membranes in a Muell- 
er-Rudin test system. 
FIGS. 3A and 3B, hereinafter collectively referred to 
as FIG. 3 shows current-voltage curves for ion conduc- 
tion in two thin film plastic membranes, compared to a 
conventional phospholipid bilayer membrane, to dem- 
onstrate the effect of surface electric charge on ion 
currents. 
FIG. 4 shows a time history for a polylaurylmetha- 
crylatelipid composite membrane with endogenous 
gramicidin ion channels, to demonstrate its durability 
toward physical and electrical voltage stresses. 
FIG. 5 shows the effects of protein-blocker conju- 
gates and immunochemical triggering on ion currents in 
hardened membranes containing c18 compound-lipid 
composites loaded moderately with gramicidin D ion 
channels. 
FIG. 6 shows the effects of protein-blocker conju- 
gates and immunochemical triggering in hardened 
membranes containing acrylic polymer-lipid compos- 
ites loaded heavily with gramicidin D ion channels. 
FIG. 7 shows a time course for an acrylic polymer- 
lipid composite membrane containing calcium channel 
proteins, to demonstrate the durability of this system to 
voltage stresses. 
FIG. 8 shows the effects of activators and blockers on 
voltage-dependent membrane noise due to calcium 
channel proteins in the FIG. 7 membrane, to demon- 
strate retention of physiological activity, regulation and 
control under conditions applicable in an artificial sen- 
sor system. 
FIG. 9 shows the effects of activators and blockers on 
voltage-dependent membrane noise due to calcium 
channel proteins in an acrylic polymer-lipid membrane 
prepared by means of a dimethylsulfoxide-mediated 
phase separation, to further demonstrate retention of 
physiological activity, regulation and control under 
conditions applicable in an artificial sensor system. 
DETAILED DESCRIPTION 
FIG. 1 shows a schematic view of the biosensor sys- 
60 tem, including the bioresponse simulator module fit- 
tioning as a biochemical switch 1 with the recognition 
biomolecule 2 and an indicator module 3 with the gated 
membrane 4 affixed to a conductive measuring surface 
electrode 5. A self-contained direct current voltage 
65 source 6 and an indicator means output 7 are connected 
in a biosensor circuit by means of a poised polarizing 
electrode 8, contacted with the biochemical switch. 
The individual components as shown in FIG. 1 are 
7 
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exaggerated for visual clarity, and are not dimensionally dicyclohexylcarbodiimide in anhydrous dimethylsulf- 
to scale. oxide containing 10 mM H3P04 catalyst for 3-4 hours at 
In the poised state, the recognition material conju- 40" C. The reaction can be verified by the appearance of 
gated to a channel blocker 2 is bound to the gate mate- dicyclohexylurea or by a positive 2,4,-dinitrophenylhy- 
rial creating ion channels 9 in the membrane 4 in such a 5 drazine test. The tetrodotoxin oxidation product is then 
manner as to effectively block ion permeation through reacted with an organic amine or amino acid in the 
the ion channels 9. Exposure of the sensor to a chemical presence of 12 mM NaCNBH3 in 20% aqueous metha- 
or biological target agent elicits a reaction with the nol for 24-48 hours at loo' C., to give a covalently 
recognition material conjugated to the channel blocker conjugated tetrodotoxin-amino derivative. 
2, pulling it away from the gate material and enabling an 10 An immunoglobulin-gadolinium complex of the pres- 
ion current to flow across the membrane 4. This system ent invention may be prepared as follows or in the ap- 
thus functions as a biochemical switch. The resulting propriate manner. An immunoglobulin type antibody 
current surge is sensed at an electrode surface 5 in the directed against one or more specific antigens, isolated 
transducer 3, triggering an alarm signal or other indica- and purified by means of methods conventionally 
tor response. Unlike prior art methods, such as U.S. Pat. 15 known in the art, is concentrated by conventional 
Nos. 4,637,861 and 4,776,944 and European Patent appl. means to a concentration of at least 0.01 mM (for exam- 
304,947, in which selectivity enabling detection of ple, 4-10 mg protein/mL). The solution is titrated volu- 
chemical or biological agents is contained together with metrically with 1 mM GdC13 in 5 mM imidazole buffer 
the ion channels, the present invention utilizes for de- (pH= 7.0) to a molar stoichiometry on the order of 1:l. 
tection selectivity a target agent-recognizing biomole- 20 Binding of gadolinium to the immunoglobulin protein is 
cule conjugated to a common channel blocker in a bio- verified spectrophotometrically, by mixing one volume 
chemical switch module. of 1 mM murexide to 100 volumes of the 0.01 mM Gd- 
Provision of a reversible channel blocker is a novel IgG complex solution, and comparing its visible spec- 
feature of the present invention, which among other trum in the region of 470 nm versus 540 nm against a 
things enables sensor regeneration by replacing the 25 comparable spectrum for free murexide alone. Typi- 
outer liquid layer comprising the bioresponse simulator cally, under these conditions, the difference is indistin- 
1. An additional inventive feature is the ability to use a guishable from zero. The Gd-IgG complex is thus ready 
single common gate membrane composition for all for use in the invention. 
classes of analytes. The gate membrane composition is The antibody may also be dissociated by methods 
designed to maximize current flow in the exposed state, 30 conventionally known in the art into light chain sub- 
thus simplifying the polarizing and detection electronic units ("IgG-L") and heavy chain subunits ("IgG-H'), 
components relative to prior art methods cited above. and the two subunit fractions separated and collected. 
The biochemical switch module 1 generally consists The heavy chain H solution is titrated volumetrically 
of a hydrophilic film forming layer containing in a with 1 mM GdCl3 in 5 mM imidazole buffer (pH=7.0) 
buffer solution of substantially neutral pH a recognition 35 to a molar stoichiometry on the order of 1:1, and veri- 
biomolecule for the target agent to which is conjugated fied as above. The Gd-IgG-H complex is then admixed 
a channel blocker substance which prevents ion perme- with the light chain (IgG-L) solution to reconstitute the 
ation through the gate membrane 4. The layer may be active antibody into the blocker-conjugated recognition 
stabilized by gelatin or the like. Examples of the recog- biomolecule of the invention. This operation prevents 
nition biomolecule include proteins such as immuno- 40 the formation of lanthanide-light chain conjugates, thus 
globulin type antibodies or albumins which may or may decreasing the proportion of channel blockers that are 
not (depending on the desired target agent) have at- not conjugated with the recognition moiety. 
tached thereto a hapten or a nucleic acid segment or a Examples of divalent or polyvalent cations useful as 
protein segment. Thus, immunoglobulin (IgG, IgM, channel blockers include the divalent cations Ca(II), 
etc.) type antibodies are useful for the detection of spe- 45 Sr(II), Ba(II), Cd(II), among others; and trivalent lan- 
cific antigens of interest. Chemically attached immuno- thanide cations such as La(III), Eu(III), Dy(III), 
globulins or albumins are useful for the detection of Gd(III), and the like; and complex ions such as ruthe- 
specific antibodies of interest, or specific genetic mate- nium red. Lanthanides as a class are well known to act 
rial fragments, or the like. Methods for covalent attach- similarly. Polyvalent cations, particularly the lantha- 
ment of haptens and nucleic acid derivatives to proteins SO nides, are preferred because of their substantially 
such as immunoglobulins and albumins are well known greater aftinity as channel blockers. Effective blockage 
and conventionally available (e.g., European Patent is achieved at concentrations some three orders of mag- 
appl. 149,405, in which bifunctional fixation with glutar- nitude lower than for the divalent cations. Conjugation 
aldehyde effects the attachment.). of lanthanide ions to the protein moiety may occur via 
Channel blocker materials include bulky cations such 55 coordination bonding, and may be performed in aque- 
as guanidinium compounds, and divalent or polyvalent ous buffer solutions or while the cation is bound to ion 
cations. Examples of the former include agents such as channels in the gate membrane. In the latter case, the 
tetrodotoxin and saxitoxin, and also neurotoxic organic channels remain blocked. Reaction of the recognition 
derivatives such as tetramethylguanidine. Conjugation protein-conjugated channel blocker with the analyte of 
methods for guanidinium toxins have been described by 60 interest at the ion channel site in the gate membrane 
Chicheportiche et al. (1980) European J.  Biochemistry results in removal of the blocker from the ion channel, 
104: 617-623. and the onset of an ion current. 
A tetrodotoxin molecule may be covalently associ- Ion channels conductive to monovalent or polyvalent 
ated with a protein such as serum albumin by Pfitzner- ions serve as the gate material in the gate membrane 4. 
Moffatt oxidation of tetrodotoxin alcohol function, 65 Examples include physiological sodium channel prote- 
Schiff-base formation with tritiated amines, and reduc- ins, acetylcholine receptor protein, physiological cal- 
tion of the imino-function by NaCNBH3. In the first cium channel proteins, and channel-forming antibiotics 
step, tetrodotoxin is reacted with a 5:1 molar excess of such as the gramicidins (Le., gramicidins A, A', D or S) 
5.328.847 
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Gramicidins are advantageous because of their high 
conductance, stability, ease of handling, high loading 
capacity and availability. 
In a gate membrane, gramicidin D forms two types of 
channels having different conductance. The channels 
are formed by dimers of two gramicidin D monomers. 
A monomer could form a channel in a monolayer mem- 
brane. Gramicidin S also forms ion channels but has a 
different structure from gramicidin D, and different 
sensitivity to channel blockers. 
Physiological membranes containing ion channels 
can be used directly, and possess the advantage of being 
functional without any requirement for isolation or 
insertion for reconstitution into sensor membranes. As 
one example, cell membranes of viable bacteria can be 
fused directly into the sensor, to detect viability in the 
presence of dead cellular debris. In this case, the endog- 
enous -70 mV potential associated with viable cells 
serves to drive the ion current detected by the sensor 
(the poising potential of the sensor being set otherwise 
near 0 mV). The live bacteria serve as a biochemical 
switch and provide gates for a hydrophobic membrane, 
and a voltage source for the measuring device. 
Alternatively, ion channels can, in some cases, be 
inserted from solution phase into artificial membranes 
previously prepared using conventional 
Langmuir-Blodgett techniques, or by vesicle transfer, 
or by direct adsorption or absorption. If gramicidins are 
selected, one can use either monolayer or bilayer mem- 
brane structures. Lipid bilayers containing hundreds, 
and even thousands, of channels (either gramicidin D or 
gramicidin S) within a pinhole area have been observed, 
conducting ion currents potentially as high as 0.1-1.0 
mA/cmZ. Preferably, gramicidin channels can be 
formed during preparation of the membrane, thus obvi- 
ating the later insertion step. 
The gate membrane consists of a hydrophobic mate- 
rial which is essentially impermeable to ions, particu- 
larly monovalent cations. Membranes can be prepared 
from phospholipids, or from polymerizable unsaturated 
organic compounds such as diacetylenic fatty acid de- 
rivatives, as in Hub, H. H., B. Hupfer, H. Koch, and H. 
Ringsdorf (1981) “Polymerization of Lipid and Lyso- 
lipid Like Diacetylenes in Monolayers and Bilayers,” J. 
Macromolecular Science-Chemistry A15: 701-715, or 
the like. 
Polymerizable lysophospholipid, phospholipid-like 
monomers, and phospholipid analogs containing diace- 
tylene, butadiene or vinyl moieties are synthesized, 
where diacetylene moiety is the polymerizable unit. 
Monolayers of fatty acid or alcohol derivatives with 
simple ammonium, ether, amine, or phosphorus contain- 
ing head groups are spread from chloroform solutions at 
the gas-water interface. Liposomes are prepared by 
sonication of aqueous suspensions of the monomers in 
water under nitrogen at 50” C. Polymerization is 
achieved by irradiation of these solutions with multi- 
chromatic light (Hg high pressure lamp) at 18” C. with 
an energy of 5 mW/cm2 at the water surface under 
10 
Plastic materials, either alone or in combination with 
lipids, may be used in the thin membrane of the present 
invention. Examples of plastic membrane compositions 
include polyvinylpyridine copolymers, or in preferred 
5 embodiments acrylic polymers such as polylauryl meth- 
acrylate, or a carboxylated acrylamide polymer such as 
a latex marketed under the trade name “RHOPLEX 
N580.” Membranes can be prepared by Langmuir-Blod- 
gett techniques, or by capillary thinning across an ori- 
10 fice separating two fluid phases in electrical contact 
with the sensor electrodes, or by evaporative or centrif- 
ugal thinning onto an electrode surface. 
In the present invention, it is envisioned that conven- 
tional microelectronic configurations will serve ade- 
15 quately to supply power for the sensor, provide a con- 
stant direct current voltage in the poised state, and 
measure the ion current surge following an exposure 
trigger. For example, a conventional battery powered 
voltage source supports both the poised potential and 
20 the measuring electrode. (Configurations such as those 
conventionally used in digital watch displays and audi- 
ble alarms may suffice.) The triggered current is antici- 
pated to greatly exceed any base level ion current re- 
sulting from electrode bias. 
Additionally, it may be desirable to incorporate into 
the detection electronics a provision for membrane 
integrity determination, based on the electrical noise 
accompanying a triggered current signal. The appear- 
ance of opening and closing events of ion channels in 
30 membranes as rapid fluctuations in membrane current is 
well known, and can be measured either in time domain 
or, as its Fourier transform, in frequency domain. In 
time domain, as exemplified by E. Neher and B. Sakman 
(1976) “Single-Channel Currents Recorded from Mem- 
35 brane of Denervated Frog Muscle Fibers,” Nature 260: 
pp 799-802, fluctuation noise due to ion channel activity 
is identified by a periodic frequency histogram of inci- 
dents. Periodicity would be absent in a ruptured mem- 
brane. For a highly loaded membrane, the noise enve- 
40 lope is autocorrelated, or averaged, to verify open ion 
channel events as the origin of the triggered electric 
current signal. In frequency domain, as exemplified by 
G. Feher and M. Weissman (1973) “Fluctuation Spec- 
troscopy: Determination of Chemical Reaction Kinetics 
45 from the Frequency Spectrum of Fluctuations,” Proc. 
Nut. Acad. Sci US. 70: pp 870-875, a small AC voltage 
component is overlaid upon the DC voltage at which 
the system is poised. Fluctuation noise is then deter- 
mined as a function of the AC frequency. In the present 
50 invention, absence of (frequency-dependent) noise is 
suggestive of membrane rupture. 
For purposes of further illustrating the embodiments 
of the current invention set forth above and in the fol- 
lowing examples, quantitative ranges for various param- 
55 eters can be provided to assist those of skill in the art in 
practicing the invention. It should be understood that 
the numerical ranges are illustrative, and not necessarily 
restrictive, because there are many variables which can 
be adjusted to achieve the desired result of sensitivity to 
25 
nitrogen. The W initiated polymerization is a topo- 60 a target agent. 
chemical reaction and does not take place in solution. With respect to the gate material, the number of 
Formation of polymeric monolayers or liposomes from channels per mmzmembrane area may be in the range of 
the diacetylenic monomers is indicated by a color from about 50 to about 109 for gramicidin D and grami- 
change from colorless via blue to red, and is also estab- cidin S. There are two preferred ranges. The lower 
lished by their enhanced stability. Polymer liposomes 65 range of about 300 to about 103 is preferred for configu- 
are stable for months, cannot be destroyed by organic rations in which a simultaneous noise analysis measure- 
solvents, and can be viewed by scanning electron mi- ment is desired in the detection electronics. The upper 
croscopy. range of about 3 x 104 to about 106 is preferred for em- 
5,328,847 
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bodiments in which simplicity is more important in the foodstuffs, bacterial cell fragments or debris thereof 
measurement electronics. Ion channel loading density is particularly for infectious organisms, hepatitis viruses 
quadratically proportional to nominal concentration of or fragments thereof, human antibodies to antibiotics 
the antibiotic. For example, 4 nM gramicidin (Le., for detection of allergic sensitivity, messenger proteins 
4 X  10-6mM) gives a channel density of about 60/mm2 5 for immunosuppression, or enterotoxins for food poi- 
but 300 nM gives a channel density of approx. soning detection. Without doubt, the present invention 
35,W/mm2. could be similarly designed to detect many other target 
With regard to other channels, such as the calcium biomolecules, far too numerous to mention specifically, 
channel, the sodium channel, or the acetylcholine chan- as the needs dictate. Use of the present invention is 
nel, the same ranges are appropriate. The upper limit of 10 anticipated in health care industries, medical and phar- 
the broad range corresponds to a packing density on the maceutical laboratory operations, personal screening 
order of 1% of the total available membrane area m u -  applications, quality control in food processing and 
pied by the protein. distribution, gene product quality control in genetic 
The recognition moiety concentration may be ex- biotechnology industries, among others. 
pressed in terms of number per channel or nmok/mm2. 15 Embodiments of the present invention are described 
A range of from 1 to about 109 molecules per channel, in the examples. 
or from about 10-10 to about 10-1 nmols/mm2is feasi- 
ble. A range of from about 102 to about 5 X 107 per 
channel or about 10-8 to about 2 X  nmok/mm2is TO the cis- chamber ofa  Mueller-Rudin bilayer mem- 
preferred. Ranges are affected by stoichiometry of rec- 20 brane apparatus (Urban, B. W., S. B. Hladky, and D. A. 
ognition moiety to gate material channels, and by the Haydon (1980) “Ion Movements in Gramicidin Pores 
thickness of the switch layer. An Example of Single File Transport,” Biochimica et 
Channel blocker concentration may range from about Bjophvsica Acto 602: 33 1-34, for example), gramicidin 
1 to about 10 moles per mole of recognition moiety, D was added to a total bulk concentration of 8 nM, and 
preferably in the range of about 1 to about 2. The nature 25 allowed to diffuse into a membrane of brain phos- 
Of the relationship between the channel, the blocker, phatidylcholine and phosphatidylethanolamine lipids 
and the recognition moiety Will determine the most (Avan& Birmingham, Ala.) in n-decane which had 
appropriate ratios. applied by streaking across a 0.2 mm orifice in the appa- 
The switch layer thickness may range from about ratus. 
A Mueller-Rudin black film apparatus for membrane 
preferred thickness would lie between 0.001-0.1 mm* conductance measurements consists of two cells, one in 
The thickness of the gate membrane may lie in the range which the contents could be stirred and exchanged, 
of from about 3X mm, Preferably separated by an orifice across which a membrane is 
about 5 X 10-6 to about 2 X applied. Two Ag-AgC1 electrodes are used, one in each 
The D.C. component ofthe transmembrane voltages 35 cell. One electrode was connected to a low-impedance 
typically employed consistent with the invention range potentiometer, the other to the negative input of a high- 
frorn to about 2o v, Preferably in a lower range Of impedance operational amplifier. An equivalent circuit 
from about 0 to about $1-0.1 v ,  or in a higher range diagram is shown in FIG. 2, for the black film and 
of from about 1 to about 3 V. The AC component, current-to-voltage amplifier. In it, noise originating 
when desired for noise analysis, may range from about 40 from the membrane (VMnMn=iMnRm), the feedback resis- 
0 to about 10 mV. tor (VR”=[~~TR$, where kT is the thermal energy 
The detectable membrane current surge resulting and Af the frequency bandwidth), and the operational 
from operation of the biochemical switch may range amplifier wAn =approx. 0.008 m ~ ,  and iZapprox. 5 
from about 10 PA to about 10 With D.C. voltage in fA) affect the output voltage (V,,), according to the 
the lower preferred range, the current surge will prefer- 45 following formula: 
ably fall in the range of from about 10 to about 100 PA. 
In the higher preferred range of D.C. voltage, the de- 
tectable current surge will preferably fall within the 
range of about 0.01 to about 0.10 mA. 
EXAMPLE 1 
mm to about 0.2 For Practical PuVosesi a 30 
to about 
mm. 
‘”‘ = - 
In the various embodiments of the invention, highly 50 zf Zf R m  zf + v A n ( g + l ) + z j A n  ‘ “ ~  + ‘Rn- Rf i- vMn- sensitive biosensors may be constructed. The sensitivity 
of a biosensor in accordance with the invention to tar- 
get agents is much greater than a sensor relying directly A 1-10 Gigaohm feedback resistor @h, the major noise 
on chemical or physical properties of the target agent, source other than the membrane, contributes less than 
and may be as great as 10-13 nmols. In typical embodi- 55 0.1 pA current noise. The two aqueous compartments 
ments, the target agent may be detected at conentra- of the bilayer chamber are filled with identical electro- 
tions ranging from about 10-10 to about 10-4 nmols. lyte solution, a voltage applied across the membrane, 
The speed of the detection reaction may range from less and the resulting discrete current steps (typically 0.1-10 
than 1 second to over 6 hours, but is preferably within PA) measured. 
the range of about 5 seconds to about 15 minutes. Four discrete ion channels formed from the gramici- 
The embodiments of the invention are best under- din dimers, each one conducting 0.95 pA at a transmem- 
stood from the examples, although the numerical ranges brane potential of -60 mV. Addition of aqueous 
provided above can help understand how to obtain the DyCI3 to a final concentration of 0.025 mM in both cis- 
benefits of the invention. and trans- chambers lowered the ion channel current to 
Examples of target agents whose detection by the 65 0.85 PA. Further DyCI3 addition to 0.050 mM dropped 
sensor of the present invention would be particularly the ion channel current below 0.2 PA, thus effectively 
useful include: environmental pollutants, AIDS virus or blocking the channels. Successive additions of bovine 
antibodies or fragments thereof, botulinum toxin in serum albumin (BSA) to the system with Dy-blocked 
60 
13 
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TABLE 1 
Ion Current Across Membrane (PA) 
channels resulted in gramicidin channel current levels 
of 0.3 pA at 0.0065 mM protein and 0.4 pA at 0.027 mM 
protein, respectively. Gramicidin channels remained 
substantially blocked, despite the fact that essentially all (mv) State State 
protein. Control experiments in which free BSA was 
added to a level of 0.010 mM showed no effect on gram- 
EXAMPLE 2 
Dy(II1)-bound bovine serum albumin was prepared 
by titrating a 1 mM solution of the protein in imidazole EXAMPLE 4 
buffer with DyCI3 to a final concentration of 5 mM. At 
the 5:1 mol ratio oflanthanide, the free Dy(II1) concen- C17H31CH20H plus 2.0 mg of the diunsaturated aide- tration was less than 0.010 mM based on colorimetric 15 hyde C17H31CH0 Cboth ,,c18,, compounds, the Same as 
analysis with murexide. Aliquots of the Dy(II1)-protein those used in Example 3, above) was mixed in o.4 mL of complex were then added to the cis- chamber of the a CHC13 containing 1.8 mg phosphatidylserine bilayer membrane apparatus described above in Exam- (“PS’’, Avanti, Birmingham, Ala.) and 2.2 mg of phos- ple 1. Two discrete ion channels were apparent in the phatidylethanolamine (PE) which, after solvent evapo- 
initial addition of 2 nM, with conductance of 1.17 pA ane:n-decane. Omission of the c18 carboxylic acid de- each at -65 mV. Addition of the Dy(II1)-protein com- 
of the free Dy(1II) ions had been sequestered by the 5 0 0 0 0 
- 20 -0.2 -0.45 -0.25 
-40 -0.35 -0.8 -0.5 
-60 -0.45 -1.3 -0.7 
icidin channel current. - 80 -0.65 -1.7 -0.95 
-100‘ -0.8 -2.2 - 1.2 
10 
1.2 mg of a diunsaturated alcohol of the 
phospholipid membrane with gramicidin from an 2o ration under N2, was mixed into 0.12 mL of 1:1 n-hex- 
plex to a concentration of0.035 mM reduced the grami- 
cidin channel current to 0.15 PA. No free Dy(1II) was 
nvative Of was to improve both the 
Of membranes toward polyvalent cations and 
25 the selectivity of Dy-protein conjugates as in Example 2 
Channel blockage occurred rapidly, within seconds, for gramicidin channels. Surface potential effects of 
channel current of 0.62 p ~ ,  which represents approxi- sites might be eliminated by omission of the Cis carbox- 
mately 50% inhibition. 3o ylic acid component. Except for the solvent evapora- 
The biochemical switch was thus turned on by a tion, all preparative and use steps were carried out aero- 
target agent. Subsequent addition of antibody against bically~ with c18 
bovine SeNm albumin r a n t i - ~ s N , )  elicited a resump- which were noticeably yellow from partial autoxidation 
tion of gramicidin channel current, to a level of 0.97 p~ (‘‘lipid peroxidation,” verified spectrophotometrically). 
at 0.0025 mM antibody, and 1.0-1.1 pA at 0.0035 mM 35 The membrane was prepared as in 
antibody. Thus, an immunological reaction o fa  protein- Overvoltage transients of some 15-16 V across the 
conjugated gramicidin channel blocker effectively re- membrane result from the act of turning off then turning 
moves the blocking agent from the ion channels. This on the main Power to the Mueller-Rudin apparatus. 
example demonstrates the functioning of a biochemical With ordinary phospholipids such as those used in Ex- 
switch which is alternately turned off by a channel 40 amples 1 and 2, this procedure instantly explodes phos- 
blocker then turned on by a target agent. pholipid bilayer membranes. Partially oxidized phos- 
pholipids conventionally give membranes which are 
even more fragile. With the present organic composi- 
A hydrophobic mixture containing 51.5 mg ofa diun- tion, overvoitage spikes across the membrane did not 
saturated aldehyde of the general formula C17H29CHO 45 came rupture, through at least Seven ‘‘C$f-On’’ cycles of 
(melting point, approximately 30” c.), 22 mg of the the power source. Despite the suboptimal materials and 
corresponding alcohol, C17H29CH20H, 12 mg of the handling conditions, bilayer ~ e d x a n e s  with exceP- 
corresponding carboxylic acid C17H29COOH, and 4 tional physical stability were obtained-far superior to 
mg of n-decane, was dissolved into 0.2 mL n-hexane. COnventional lipid bilayers. 
EXAMPLE 5 This mixture solidifies as the hexane evaporates or dis- 50 
appears. When streaked over the pinhole in a Mueller- 
Rudin apparatus as described above in Example 1, a in order to examine charge related effects on stability 
membrane formed with the conductance characteristics and electrical activity of plastic bilayer membranes, two 
Shown for the ‘‘Control’’ column in Table 1. Addition of thin film plastic derivatives were examined, as in Exam- 
gramicidin D to a bulk concentration of 10 nM in the 55 ple 1. One material (“E”) consisted of 0.01 mL of a IN 
cis- chamber, a quantity sufficient to maintain 3-5 ion pol~(2-vin~lp~ridine-co-st~rene, from Aldrich, Mil- 
channels in the membrane, increased the conductance waukee, Wis.) solution (with respect to pyridine-nitro- 
as shown in the “Open” column in Table 1. Addition of gen) in toluene, mixed with 0.03 mL of an n-decane 
a 1:l Dy(II1)-BSA complex, to a fmal bulk concentra- solution of partially oxidized 0.6 mg PS and 0.75 mg PE 
tion of 0.020 mM in both the cis- and transchambers, 60 (as in Example 4). The second material consisted of the 
resulted in a reduced conductance, as shown in the N-methylated polymer (“F”) prepared by titrating pol- 
“Blocked” column of Table l. Depending on membrane ymer “E’ with a 1N solution of CH3CI in diethyl ether, 
composition, ion currents with gramicidin channels can and containing the same lipid composition as “E’. The 
range from -0.5 to - 1.2 pA at - 100 mV. The Table latter material “F” contained a large excess of surface 
1 results are consistent with the presence of 1-3 gramici- 65 cations, and was expected to exhibit significantly in- 
din channels frozen in an open configuration in a solid creased conductance in a membrane. 
membrane, subject to blockage by a lanthanide-protein FIG. 3 shows steady-state current voltage curves for 
conjugate. the two plastic membrane preparations “E’ and “F’, 
detected in the system. 
and was essentially complete. A similar addition of the 
complex to 0.008 mM concentration resulted in an ion 
negative charges which could interfere with Dy-protein 
conjugate interactions by presenting too many bonding 
and phospholipid 
EXAMPLE 3 
5.328.847 
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relative to that for a pure phospholipid bilayer mem- 
brane “PL”, and a test membrane “F+G” in which 0-3 
mM gramicidin D was added to material “F” immedi- 
ately prior to preparation of the membrane. While the 
cationic N-methylated material (“F”) was more con- 
ductive, its ability to carry a gramicidin-mediated ion 
current (Curve “F+ G”) was considerably less than that 
observed for an uncharged plastic membrane material 
(Compare the curve for “F+G” in FIG. 3 with the 
curve for “1” in FIG. 6, described below in Example 8). 
A positively charged membrane reduces sensitivity, 
presumably because gramicidin produces a cation chan- 
nel, and the cations are repelled by the positive charge. 
Membranes prepared with either material “ E  or “E’ 
ruptured after 4-6 rounds of “off-on” overvoltage 
spikes as in Example 4. This nonetheless represented an 
improvement over bilayer membranes prepared with 
conventional phospholipids as in Examples 1 and 2. 
EXAMPLE 6 
A hybrid lipid-plastic material was prepared by air 
drying under direct sunlight 0.27 mL of an aged CHCI3 
solution containing 1.2 mg PS and 1.5 mg PE. This 
procedure assists further lipid peroxidation in the mate- 
rial. After resuspension into 0.05 mL unfiltered n-dec- 
ane, this material was admixed with 0.05 mL of a solu- 
tion containing one part polylauryl methacrylate (20% 
in tetrahydrofuran, Aldrich, Milwaukee, Wis.) and two 
parts n-hexane. The mixture was then diluted further 
with 0.05 mL n-decane and 0.05 mL n-hexane, giving a 
final solids loading of 4.0 mg polylauryl methacrylate 
and 2.7 mg phospholipids. This mixture contained 
gramicidin D at endogenous contamination levels only 
(approximately 10-6-10-5 mM ). Test membranes were 
prepared from these solutions by capillary thinning 
across the pinhole of a Mueller-Rudin apparatus as in 
Examples 1 and 2. 
FIG. 4 shows the time history of one such membrane. 
Applied steady-state potentials across the membrane 
(identified by “Y” in FIG. 4) varied from 0-100 mV, 
except that where indicated by “6V*5sec,” a 6-Volt 
battery was connected across the membrane for a 5 sec 
duration. Overvoltage spikes of 15-16 V generated by 
“offsn” transients (as in Example 4, above) are identi- 
fied by “X” in FIG. 4. After 27 rounds of overvoltage 
spikes, plus physical stabbing with a straight pin 
(“STABBED” in FIG. 4), the membrane remained 
intact. Following irrigation of the membrane by n-hex- 
m e  (“H” in FIG. 4) to re-fluidize the membrane mate- 
rial, performed by pipetting 0.002-0.005 mL of the liq- 
uid to within 0.1 mm of the membrane from the cis- 
chamber of the Mueller-Rudin apparatus, ion current 
transients resume in increased frequency, as shown in 
the third line of the Figure. 
Electrical noise in the figure, particularly at steady- 
state potentials of -60 to - 100 mV, is due primarily to 
the action of gramicidin D-dimer ion channels opening 
and closing as dimers associate and dissociate and is 
indicative of the plastic membrane in a highly fluid 
state. As the membrane freezes or solidifies, at times 
beyond 10 min in the figure, opening and closing events 
occur much less frequently, and the electrical noise 
level decreases. Re-fluidizing with n-hexane restores 
some of the noise transients. Autocorrelation analysis of 
16 
distinguish ion channel effects from unrelated disturb- 
ances in the membrane. 
EXAMPLE 7 
The membrane-forming material of Example 4 was 
pre-loaded with O.OOO64 mM gramicidin D to a final 
concentration of IO-SmM gramicidin D. Then, a mem- 
brane of this material was prepared by streaking it 
across the orifice of a Mueller-Rudin apparatus as in 
10 Examples 1 and 2. Subsequent capillary thinning re- 
sulted in a bilayer membrane with the conductance 
shown in curve “0’ of FIG. 5. 
FIG. 5 shows the steady-state time-weighted average 
current-voltage profiles for this membrane. The slope 
15 represents the electrical conductance (in pS) of the 
membrane, under each of the respective test conditions. 
A straight line slope indicates that Ohm’s law is obeyed 
for the present system. Curve “0’ represents the 
gramicidin-loaded membrane with a conductance of 
20 150 pS. By comparison, a similar membrane without 
any gramicidin constituent contained therein (“U”) 
gives a much smaller slope, corresponding to approxi- 
mately 14 pS conductance. 
Addition of 0.02 mM of a Dy-conjugated albumin, 
25 similar to that described Example 2, results in a conduc- 
tance decrease to 46 pS. Thus, effective ion channel 
blocking by the lanthanide-protein conjugate is demon- 
strated, although the efficiency does not quite equal that 
for the unloaded membrane (“U”) which had contained 
Presumably, blocker concentration was below the 
saturation point. In a Wheatstone bridge circuit, the 
background state is nulled, and so using concentrations 
below saturation is possible, allowing greater tolerance. 
35 Subsequent addition of 0.01 mM antibody against the 
Dy-conjugated protein of curve “0’ increases the elec- 
trical conductance of the membrane to the 100 pS state 
shown by Curve “T” of FIG. 5. These results confirm 
the value of an immunochemical trigger mechanism for 
40 chemical or biological agent detection in a hardened 
artificial membrane, and demonstrate the function of 
the biochemical switch. 
In Example 8, use of a plastic lipid composite for the 
membrane of the sensor is described, and the triggered 
45 electrical activity in response to an immunological reac- 
tion is demonstrated. Examples 9 and 10 extend these 
descriptions to the simple direct current measurement in 
a simple metal electrode chip configuration. Example 
11 describes the incorporation and use of a physiolog- 
50 ical ion channel protein, specifically calcium channels 
from mouse heart sarcoplasmic reticulum, in a plastic 
lipid composite membrane. 
EXAMPLE 8 
A hybrid lipid-plastic material similar to that in Ex- 
ample 6 was prepared by air drying a CHCI3 solution 
containing 1.2 mg PS and 1.5 mg PE. After resuspen- 
sion into 0.05 mL unfiltered n-decane, this material was 
admixed with 0.05 mL of a solution containing one part 
60 polylauryl methacrylate (20% in tetrahydrofuran) and 
two parts n-hexane. The mixture was then diluted fur- 
ther with 0.05 mL n-decane and 0.05 mL n-hexane, 
giving a final solids loading of 4.0 mg polylauryl meth- 
acrylate and 2.7 mg phospholipids. To one volume of 
5 
30 no gramicidin in its formulation. 
55 
the noise indicates electrical conductance states of 12 65 this mixture was thenadded an equal volume of 0.6 mM 
picoSiemens and 4-5 picoSiemens for the gramicidin D gramicidin D in ethanol, giving 0.2 mg in the mixture. A 
channels in this membrane composition. This demon- membrane was streaked across the orifice of a Mueller- 
strates the ability of the circuitry of the invention to Rudin apparatus as in Example 1, and its electrical con- 
5,328,847 
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TABLE 2 ductance measured from the slopes of the current-volt- age curves of FIG. 6. 
In FIG. 6, Curve “1” represents a lower limit of the 
conductance of the initial membrane, at least 3,300 pS as 
shown by the arrows pointing upward in the figure. s 
Plastic Latex Est. Film +Water 
Addition of a 1O:l stoichiometric complex of gadolini- Run Thickness Dry Chip Overlay 
um-bovine serum albumin (“Gd-albumin”), to a final 
None >0.10 >0.10 
concentration of 0.02 mM in both the cis- and trans- Fank (w/w) 1OOOOOnm 0.005-0.008 a d .  
chambers of the apparatus, lowers the conductance B I . o o / , ( ~ / ~ )  Moonm <0.004 a d .  
within the first 2 min to a value of 950 pS (curve “Z’), 10 c 18 nm 0.05 k 0.0s 0.010 
and subsequently to a lower value of 220 pS after 7 min, 
which is less than 1/15 of the original value. At this 
point, ion channels in the membrane have been effec- 10 mM gram. S 900 nm O.Oo0 0.036 
tively blocked. A subsequent addition of antibody D 0.01% (w/w) 18 nm 0.080 k n.d. 
concentration of 0.010-0.014 mM in both the cis- and (THF medium) 
0.01% (w/w) 18nm O.Oo0 O.Oo0 
(<2S% EtOH med.) trans- chambers restored the membrane conductance to 
a value of 2,100 pS, or some $ of the original electrical F 0.01% (w/w) 100 nm O.Oo0 0.026 
current. The biochemical switch was closed and (<25% EtOH med.) 
Thin Film Deposition and Membrane Conductance 
Elec. 
Conductance (mA) 
0.01% (WIW) 
medium) Same, +o,ol mL 
(50% EtOH 
c‘ 
against bovine serum albumin (“anti-BSA”) to a final 1s 0.04 
E 
+0.0018 mL of 
1omMgram.s 
o,ol% (w,w) 
(-25% EtOH med.) 
opened, yielding a measurable current surge. 20 
18 nm 0.025 C O.Oo0 
0.025 
The test membrane of this example held an estimated 
time-weighted average of 400-500 gramicidin D chan- 
nels in their open state. Sufficient gramicidin D was 
present stoichiometrically to support some 103-104 H 0.01% (w/w) 50nm 0.050 k 0.060 
only a small fraction of the available plastic material 
0.050 
(-25% EtOH med.) 
+O.S mM gram. S 
times this number of ion channels. On the other hand, 25 
volume actually accounted for the test membrane area. 
From this Example, triggered current densities on the 
tial have been shown. Because this membrane can toler- 30 aqueous Of the above latex was spread Onto a 
system capability of 600-700 d l m 2  is shown to be apparently uniform film with an estimated thickness on 
feasible. the order of 0.1 mm resulted. It was electrically non- 
conductive. 
EXAMPLE 9 In Run B, wetting proceeded less readily than in Run 
Circular steel alloy metal chips available as junction A, largely because dilution of the plastic latex also re- 
box knockouts, approximately 100-200 ,,2 in available sulted in dilution of any surface-active additives which 
surface area, serving as electrodes, were wired to simple might have been present in the original latex. Neverthe- 
resistive circuitry driven by a 1.5 V battery through a less, a good evenly spread membrane was formed, with- 
10K47K ohm resistor series and an ammeter. Gate 40 Out Obvious signs of 
membranes were applied in the gap between the amme- Run c represented a further dilution Of the latex, to a 
ter and the electrodes. Under these conditions, aqueous concentration sufficient to form a film on the order of 
films supported a current load on the order of 0.10 18 nm thickness. Surface wetting Of the metal chip re- 
mA4.6 d, which was easily distinguishable from the quired addition Of ethanol (EtOH) to a final concentra- 
< <0.01 mA currents through canola oil films. For 45 tion OfaPProximatelY <So%. However, visual inspec- 
comparison to the Example 8 results, a current surge of tion of the dried film did not reveal signs of island for- 
250 ps  translates to an effective current density on the mation. At this loading, the film thickness was within a 
order of 0.10 d at the supply voltages in this Example, factor Of 3 times the thickness Of a bilayer lipid mem- 
provided: (1) the necessary bilayer membrane can be brane (conventionalb reported to be 5-6 m). Minor 
spread Over a 100-200 mm2 area; and (2) the bilayer 50 aggregation without discrete islands, and thus without 
membrane employed can withstand supply potentials of zones of direct electrical contact with the metal surface, 
1.5-9.0 V. might not be visually detected at these dimensions. 
Metal test chips were coated with 0.0184.020 mL of Separate experimental tests, in which higher ethanol 
a diluted or undiluted latex emulsion of a carboxylated concentrations were used, revealed substantial island 
acrylamide polymer marketed under the trade name 55 formation. 
“RHOPLEX N580” which was spread gravitationally In Run C ,  a solution of gramicidin S was plied di- 
over the entire area of the chip. Conduc,tance due to a rectly over the membrane of Run C by careful surface 
1.5 V direct current source was measured amperometri- application in a manner familiar to one of skill in the art. 
cally with an ovoid Ag-solder electrode (Area=ap- After drying, the conductance of the film was measured 
prox. 15-20 mm2) and resistive breadboard circuitry. In M) in the dry state, then again after applying an aqueous 
the absence of an effective electrical bamer (e.g., mem- KCl overlay. The substantial current increase observed 
brane), a stable current of >0.100 mA was obtained. in the wet state, but not dry, strongly suggests a 
The emulsion was allowed to dry in air into a surface gramicidin-mediated conduction mechanism in the test 
film which could then be analyzed in the dry state, chip. 
overlaid with an aqueous salt solution or gel, and ana- 65 Run D attempted to produce essentially the same 
lyzed again wet. In some experiments, a small volume of membrane structure as Run C. Only the solvent vehicle 
an ethanolic solution of gramicidin S was also added to (in this case, tetrahydrofuran, “THF,” instead of an 
the system. Table 2 shows the results. aqueous ethanol mixture) differed. Island formation was 
order of at least 6-7 mA/mz at -0.06 V stimulus poten- 
ate stimulus potentials as high as 6 V (Example 6), a 
In Run “A” (Table 2), OSol8 mL Of a 56% (w/w) 
proceeded readily, and an loo mm2 
3s 
formation. 
5,328,847 
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visually evident, and the electrical conductance mea- B and D indicate gramicidin channel blocking action of 
surements pointed to the same conclusion. THF is a the Gd-BSA conjugate. In this example, the magnitude 
lipophilic but chaotropic liquid, which was originally of the effect appeared to be masked somewhat by an 
considered a good candidate to reversibly break down unexplained influence of the Gd-BSA conjugate, which 
the Structure Of the latex emulsion particles into a ho- 5 increases the current in the absence of gramicidin &an- 
mogeneous plastic solution. In fact, THF did not effec- 
tively dissolve the emulsion in this example. Other sol- 
vents which also present difficulties with effective dis- 
solving of the emulsion include CH2C12 and methano- 
lacetone. 
as shown by chips A and c. 
EXAMPLE 11 
A solution 1 mg of polylauryl methacry- 
lo late plus 0.60 mg PS and 0.75 mg PE prepared as in Run E conditions were to Run c, but Example 8 in 0.025 mL of n-hexane/to]uene (4:1 v/v) 
was mixed with 0.02 mL of an aqueous buffer suspen- ing less in the surface preparation and spreading step. This run is shown in Table 1, as a control condition 
for Run F. A good membrane was formed on the sion of sarcoplasmic reticulum vesicles isolated from 
conditions and wet (i.e., with an aqueous KC] overlay). search Institute, King of Prussia, Pa.). A milky emulsion 
added to the latex emul- resulted. This material was plied across a 1 mm diame- 
sion On the test chip, which was then air dried and ter hole Of a Mueller-Rudin Cup containing in both the 
evaluated. In the dry state, no measurable conductance cis- and trans- chambers a solution of 0.25 M KCl PIUS 
was observed. Hence, an intact membrane had formed. 20 0.08 M sodium phosphate-bicarbonate buffer (pH=7.4). 
After applying an aqueous KCl solution overlay, how- A stable membrane resulted, despite the fact that the 
ever, the current increased to 0.026 mA, consistent with material applied was a heterogeneous aqueous suspen- 
a gramicidin S-mediated conduction mechanism. sion including cell fragments. 
Runs G and H were similar to Runs E and F respec- FIG. 7 shows a time course for the membrane, includ- 
surface, which was non-conductive under both dry 15 mouse cardiac muscle (Philadelphia Biomedical Re- 
R~~ F, s 
tively, except that gramicidin S in Run H was added to 25 ing noise measurements pertaining to the Mueller- 
the stock latex emulsion prior to application to the test Rudin apparatus (Example 1) and to ion channel activ- 
chip. 0.5 mL of 10 mM Gramicidin S in ethanol was 
mL of this emulsion was then plied to the test chip, and 
sufficient ethanol added (final concentration of approxi- 30 
mately 25%) to assist wetting and spreading of the thin 
film. In these test runs, surface preparation and material 
with signs of island formation beginning to appear. 
Electrical current readings in the dry state for both runs 35 
had become less stable. However, wet conductance 
measurements remained stable, with a substantial in- 
crease still observed due to gramicidin S (Run H). 
These results demonstrate electrical conductance due 
ity due to the sarcoplasmic reticulum calcium channels 
left-hand region of FIG. 7 (transmembrane potential 
diate region, in which the transmembrane was 
equal to 1 V, the membrane current was off scale, ex- 
measure. At the right-hand region of FIG. 7, the trans- 
membrane potentia’ was lowered to loo mV* and a 
membrane current noise pattern indicative of ion chan- 
nel activity was evident. This time course demonstrated 
that the membrane, Over a 1 mm diameter ofifice, had 
or breakdown. It is conventionally known that phos- 
pholipid membranes immediately explode under such a 
stress. 
Four metal chips were coated with 0.018 mL of a The 95% width of membrane current noise at volt- 
0.01% aqueous latex emulsion of a carboxylated acryl- 45 age, which is related to ion channel opening and closing 
amide polymer marketed under the trade name “RHO- events by 2 v n ,  where n=the time-weighted average 
PLEX N580’’ as in Example 9, with o.Ooo1 mM Fami- number of open ion channels, was determined as a func- 
cidin D present in the emulsion for two of the chips tion of applied transmembrane voltage. 
@+D) and absent from the other two (A and c),  and m e  FIG. 8 membrane contained m undetermined 
air dried. Electric current measurements with a 1.5 v 50 number of sarcoplasmic reticulum calcium channels. 
the chips overlaid either with an aqueous 10 mM KCI 
added to 10 mL of the stock 0.01% latex emUlSiOn. 0.018 embedded in the membrane. me noise at the 
=o) is dominated by the electronics. In the 
’Preading were becoming more ceeding the capacity of the detection e]ectronics to 
to gramicidin S activity on a metal electrode chip, mea- 40 withstood a 1 v stress for some 40 sec without rupture 
surable by conventional miniature electronics. 
EXAMPLE 10 
battery as in Example 9 were then performed dry, then The abscissa Kale of FIG. 8 reprmnb the applied 
transmembrane voltage. The ordinate scale solution (A and B) or a 1 mM solution of a 5: 1 gadolini- to the noise under the stat& conditions. (&lid 
Serum (GdS-BSA) (‘ and circles), Sarcoplasmic reticuhrn only, with no activators 
55 nor inhibitors present. (Open circles), Same membrane, 
to which 5 mM magnesium-ATP, an activator of the ion 
channels, had been subsequently added to the cis- cham- 
ber. (Solid triangles), Same membrane as “0” but subse- 
Test Thick- Gramicidin Current Overlay Current 
chip neSS Content (mA) Material wet (mA) quent to a trans- addition of 0.02 mM ruthenium red, a 
potent calcium channel blocker. The activatordepend- 
A 18 nm 0.0 mM 0.02 -C 0.02 KCl-H2O .02-.03 
B 18 m O.ooO1 mM 0.01 * 0.01 KCl-H2O .056 ent increase in current noise, followed by a correspond- 
C 18 nm 0.0 mM 0.02 -C 0.02 Gds-ESA ,074 ing reversal in the presence of a blocker, indicates that 
D 1 8 m  O.ooO1 mM 0.00 * 0.01 Gds-ESA ,030 both the physiological activity and regulatory proper- 
65 ties of sarcoplasmic reticulum calcium channels are 
retained in artificial plastic membranes. The membranes 
can, furthermore, function at potentials on the order of 
volts. 
D). Table 3 shows the wet and dry ion currents. 
TABLE 3 
Est. 
Film 
The increased wet current in chip B relative to chip A 
demonstrates the effect of gramicidin D ion channel 
activity. The wet current difference between test chips 
5,328,847 
EXAMPLE 12 
A solution containing 1 mg of polylaryl methacrylate 
plus 0.60 mg PS and 0.75 mg PE prepared as in Example 
8 in 0.025 mL of dimethylsulfoxide/toluene (4:l v/v) 
was mixed with 0.02 mL of an aqueous buffer suspen- 
sion of sarcoplasmic reticulum vesicles isolated from 
mouse cardiac muscle (Philadelphia Biomedical Re- 
search Institute, King of Prussia, Pa.). A visually homo- 
geneous solution/suspension resulted. This material was 
plied across a 1 mm diameter hole of a Mueller-Rudin 
cup containing in both the cis- and trans- chambers a 
solution of 0.25 M KCI plus 0.08 M sodium phos- 
phatebicarbonate buffer (pH= 7.4). A phase separation 
resulted, in which a stable membrane formed across the 
1 mm orifice. Parallel control preparations, in which 
polylaurylmethacrylate was omitted from the medium, 
failed to give the necessary phase separation into a 
membrane. The 95% width of membrane current noise, 
which is related to ion channel opening and closing 
events by 2 d n  , where n=the time-weighted average 
number of open ion channels, was determined as a func- 
tion of applied transmembrane voltage. 
The abscissa scale of FIG. 9 represents the applied 
transmembrane voltage. The ordinate scale corresponds 
to the noise envelope under the stated conditions. (Solid 
circles), Sarcoplasmic reticulum only, initial conditions. 
No activators nor inhibitors were present. (Open cir- 
cles), Same membrane, but following addition of 20 mM 
CaCl2 to the cis- chamber, activating the sarcoplasmic 
reticulum ion channels (in much the same fashion as 
Mg-ATP). (Solid triangles), Same membrane as “0” but 
following a subsequent addition of 0.02 mM ruthenium 
red, a Ca2+ channel-blocker, to the trans- chamber. 
(Open squares), Control membrane prepared from the 
same materials, but in which sarcoplasmic reticulum 
vesicles were absent from the preparation medium. As 
in the previous example, both the activity and the regu- 
latory properties of sarcoplasmic reticulum calcium 
channel protein are retained in artificial plastic mem- 
branes. 
EXAMPLE 13 
A solution of polylaurylmethacrylate and phospho- 
lipids, as in Example 8 above, was plied into membranes 
across the orifice of a Mueller-Rudin apparatus, as in 
FIG. 1 with orifice diameters of 0.2 mm, 1.0 mm, and 5 
mm. Aqueous salt solutions of varying composition 
were present in both the cis- and trans- chambers, sepa- 
rated by the membrane. The longevities of the mem- 
branes without voltage and with applied voltage of 0.1 
V and 1 V were observed. 
5 
10 
15 
20 
25 
30 
35 
40 
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50 
Membrane longevity increased as the orifice diameter 
decreased and as the applied voltage decreased. A 5 mm 
orifice membrane lasts about 5-20 seconds without 55 
applied voltage, whereas a 0.2 mm membrane has a 
longevity running into days at an applied voltage of 0.1 
V. 
At an orifice diameter of 5 mm, membrane stability 
was limited to lifetimes on the order of 5-20 sec (n=25 60 
determinations), which is sufficiently long to permit 
penetration of a 1-2 mm diameter electrode device 
through the membrane, and thereby applying the mem- 
brane to the surface of the electrode. 
a membrane and passing an electrode through a solution 
of the biochemical switch medium to touch the gate 
membrane. The membrane is thus applied to the elec- 
Thus, the biosensor can be manufactured by forming 65 
aa LL 
trode and the biochemical switch layer is applied on top 
of the gate membrane as the electrode is withdrawn. 
It is contemplated that a standard indicator module 
(the gate membrane with measuring device) can be 
produced separately and any desired biochemical 
switch layer can be either formed on or applied to the 
indicator module to complete production of the biosen- 
sor. 
EXAMPLE 14 
Four metal chips as in Example 10 are coated with 
0.01 8-0.020 mL of a 0.01 % aqueous latex emulsion of a 
carboxylated acrylamide polymer marketed under the 
trade name “RHOPLEX N580” as in Example 9, with 
0.1 mM gramicidin D present in the emulsion for two of 
the chips and absent from the other two, and air dried. 
Estimated film thickness is approximately 18 nm. Elec- 
tric current measurements are then performed dry, then 
the chips overlaid either with an aqueous salt solution 
or a 0.02 mM solution of a 1 : 1 gadolinium-bovine serum 
albumen (Gd-BSA) complex. This lower concentration 
of blocker reduces the masking effect noted in Example 
10. 
Table 5 shows the wet and dry ion currents. Subse- 
quently, to the test chips is plied a solution containing 
approximately 0.014 mM antibody directed against bo- 
vine serum albumen (anti-BSA) as described in Example 
8 above. The resulting changes in ion currents are 
shown in Table 5. 
TABLE 5 
Current 
Test Gramicidin Current: Overlay +Anti- 
Chip DContent Dry(mA) Material Wet(mA) BSA 
A 0.0mM 0.01 f 0.01 KCl-H2O 0.010 0.010 
B 0.1 mM 0.02 f 0.02 KCl-H2O 0.080 0.080 
C 0.0 mM 0.01 f 0.01 Gd5-BSA 0.010 0.010 
D 0.1 mM 0.02 f 0.02 Gd2-BSA 0.010 0.080 
The wet current difference between test chips B and D 
indicates the eficiency of gramicidin channel blocking 
action of the Gd-BSA conjugate. The resurgence of ion 
current in test chip D following administration of anti- 
body against bovine serum albumen (anti-BSA) demon- 
strates effective triggering in the present invention in 
response to the recognition reaction of the recognition 
biomolecule in the bioresponse simulator. 
At this point, the test chips are rinsed gently with an 
exhaustive volume of 10-100 mM KCI to remove the 
overlay solutions. Electrical conductances return to the 
levels indicated by the “Wet” column for chip A (if 
gramicidin D is absent from the membrane) or chip B (if 
gramicidin is present in the membrane), regardless of 
history (including that for chip D). The sensor of the 
present invention is regenerated by repeating the gel 
overlay application procedure described above for chip 
D. The conductance of chip D then falls to the level 
shown in the “Wet” column for chip D in Table 5. 
EXAMPLE 15 
Four metal electrode chips are coated with a thin 
surface film of an acrylic polymer latex of the composi- 
tion marketed under the trade name “RHOPLEX 
N580” as in Examples 9 and 10, to an estimated average 
thickness on the order of 6-18 nm. For the control chips 
(“A” and “C” of the following Table), gramicidin D is 
omitted from the latex. For chips of the present inven- 
tion (“B’ and “D” of the following Table), gramicidin 
23 
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D is added to the stock latex emulsion to a final concen- 
tration of 0.1 mM per 1% (w:w) solids, and the resulting 
emulsion diluted with 10-100 mM KCl to a final emul- 
sion concentration of 0.01% (w:w) solids. After the film 
is plied to the electrode surface, it is air dried and tested 5 
for electrical conductance (“Dry” column of the fol- 
lowing Table). A gel overlay containing approximately 
2 mg/mL gelatin in 10-100 mM KCI as a stabilizer for 
the biochemical switch layer is plied to chips “A“ and 
“B,” representing controls which lack the recognition 10 
biomolecule &e., the protein-blocker conjugate or the 
like). A gel overlay of the same composition plus 0.01 
mM immunoglobulin-gadolinium complex (Gd-IgG, at 
approximately 1:l mole ratio) is plied to chips “C’ and 
“D,” in which the recognition biomolecule is present. 15 
Electrical conductance is then measured (“Wet” col- 
umn of the following Table). Chip “D” under this con- 
dition represents the present invention in its poised 
state. 
plex, prepared as described above, to the test chip D 
gives rise to the present invention in its poised state. The 
other test chips serve as controls in this Example. Sub- 
sequent addition of antigen to which the present IgG is 
directed, at levels approximately equal to a 1:l titer 25 
(determined immunochemically by methods conven- 
tionally known in the art) initiates a reaction with the 
-Gd-IgG in the bioresponse simulator in chip D. Table 6 
shows the results. 
TABLE 6 
Application of an immunuglobulin gadolinium com- 20 
30 
Current 
Test Gramicidin Current: Overlay + IgG 
ChiD D Content Dry (mA) Material Wet(mA) Antigen 
A 0 .0mM 0.01 -+ 0.01 KCl-HzO 0.010 0.010 35 
B 0.1 mM 0.02 -+ 0.02 KCl-H2O 0.080 0.080 
C 0.0 mM 0.01 -+ 0.01 Gdl-IgG 0.010 0.010 
D 0.1 mM 0.02 -+ 0.02 Gdl-IgG 0.010 0.080 
The wet current difference between test chips B and D 40 
indicates the efficiency of gramicidin channel blocking 
action of the Gd-IgG conjugate. The resurgence of ion 
current in test chip D following administration of anti- 
gen demonstrates effective triggering in the present 
invention in response to the recognition reaction of the 45 
recognition biomolecule in the bioresponse simulator. 
At this point, the test chips are rinsed gently with an 
exhaustive volume of 10-100 mM KCI to remove the 
overlay solutions. Electrical conductances return to the 
levels indicated by the “Wet” column for chip A (if 50 
gramicidin D is absent from the membrane) or chip B (if 
gramicidin is present in the membrane), regardless of 
history (including that for chip D). The sensor of the 
present invention is regenerated by repeating the gel 
overlay application procedure described above for chip 55 
D. The conductance of chip D then falls to the. level 
shown in the “Wet” column for chip D in Table 6. 
What is claimed is: 
1. An electrochemical biosensor capable of signalling 
a. a biochemical switch comprising a hydrophilic film 
layer containing a recognition biomolecule, the 
recognition biomolecule having an ion channel 
blocker and a recognition moiety capable of specif- 
ically binding with a target agent, 
b. a hydrophobic gate membrane comprised of mem- 
brane material and ion channel eate material. in 
the presence of a target agent, comprising 60 
65 
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c. a measuring device comprising a conductive mea- 
suring electrode in contact with the gate mem- 
brane, and means for measuring a current surge 
between the biochemical switch and the measuring 
electrode in response to exposure to a target agent. 
2. The biosensor of claim 1 wherein the recognition 
moiety is selected from the group consisting of an anti- 
body to an antigen target agent, hapten to an antibody 
target ag’ent, and antigen to an antibody target agent. 
3. The biosensor of claim 1 wherein the ion channel 
blocker is a polyvalent cation. 
4. The biosensor of claim 1 wherein the ion channel 
blocker is ruthenium red. 
5. The biosensor of claim 1 wherein the channel 
blocker is a guanidinium compound and the ion channel 
is a sodium channel. 
6. The biosensor of claim 1 wherein the ion channel 
blocker is a trivalent lanthanide. 
7. The biosensor of claim 6 wherein the lanthanide is 
selected from the group consisting of dysprosium and 
gadolinium. 
8. The biosensor of claim 1 wherein the recognition 
moiety is a protein selected from the group consisting of 
albumin and immunoglobulin. 
9. The biosensor of claim 1 wherein the gate mem- 
brane is a plastic. 
10. The biosensor of claim 1 wherein the gate mem- 
brane is a mixture of plastic and lipid. 
11. The biosensor of claim 1 wherein the gate mem- 
brane comprises a solid layer of a mixture of alcohol, 
carboxylic acid and aldehyde with about 17 carbon 
atoms. 
12. The biosensor of claim 1 wherein the gate mem- 
brane material comprises an acrylic polymer. 
13. The biosensor of claim 1 wherein the gate mem- 
brane material is selected from the group consisting of 
polylaurylmethacrylate, carboxylated polyacrylamide, 
and styrene polyvinylpyridine copolymer. 
14. The biosensor of claim 1 wherein the gate mem- 
brane material comprises a phospholipid or fatty acid 
derivative. 
15. The biosensor of claim 1 wherein the gate mate- 
rial is selected from the group consisting of channel- 
forming antibiotics, physiological ’ calcium channels, 
acetylcholine receptor channels, and physiological so- 
dium channels. 
16. The biosensor of claim 1 wherein the gate mate- 
rial is comprised of a gramicidin antibiotic ion channel. 
17. The biosensor of claim 1 wherein the measuring 
device comprises a Wheatstone bridge circuit. 
18. The biosensor of claim 1 wherein the biochemical 
switch includes gelatin, the recognition biomolecule is 
an immunoglobulin-lanthanide conjugate, the gate 
membrane is a carboxylated acrylic polymer latex with 
gramicidin ion channels, and the measuring device is a 
resistance circuit capable of measuring a current surge 
when the biosensor is exposed to antigen. 
19. The biosensor of claim 1 wherein the indicator 
means is an audible alarm. 
20. The biosensor of claim 1 wherein the indicator 
means is a visible display. 
21. The biosensor of claim 1 wherein the measuring 
device in contact with the gate membrane is con- 
structed so as to be able to be regenerated and used with 
a variety of biochemical switches. 
22. A method of using a biosensor, the method com- 
contact with the biochemical swirch, and prising: 
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providing a biochemical switch having a hydrophilic 
film layer containing a recognition biomolecule, 
23. A method of making a biosensor, the method 
comprising: 
the recognition biomolecule having an ion channel 
blocker and a recognition moiety capable of specif- 
ically binding with a target agent, a hydrophobic 
gate membrane containing ion channels in contact 
with the biochemical switch, and a measuring de- 
vice, said measuring device comprising a conduc- 
tive measuring electrode in contact with the gate 
membrane, and means for measuring a current 
surge between the biochemical switch and the mea- 
suring electrode, 
placing the biosensor in an environment suspected of 
containing a target material, 15 
contacting the biochemical switch to the suspected 
environment, and 
determining the presence of the target material. 
20 
providing a biochemical switch having a hydrophilic 
fdm layer containing a recognition biomolecule, 
the recognition biomolecule having an ion channel 
blocker and a recognition moiety capable of specif- 
ically binding with a target agent, 
providing a hydrophobic gate membrane containing 
ion channels, 
providing a measuring device, said measuring device 
comprising a conductive measuring electrode and 
means for measuring a current surge between the 
biochemical switch and the measuring electrode, 
connecting the gate membrane to the measuring de- 
vice, and 
connecting the biochemical switch with the gate 
membrane. * * * * *  
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